Histone deacetylase inhibitors in oral squamous cell carcinoma treatment.
about
Histone deacetylase (HDAC)-1, -2, -4 and -6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survivalIncreased histone deacetylase 6 expression serves as a favorable prognostic factor for diffuse large B-cell lymphoma.
P2860
Histone deacetylase inhibitors in oral squamous cell carcinoma treatment.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Histone deacetylase inhibitors in oral squamous cell carcinoma treatment.
@en
type
label
Histone deacetylase inhibitors in oral squamous cell carcinoma treatment.
@en
prefLabel
Histone deacetylase inhibitors in oral squamous cell carcinoma treatment.
@en
P2093
P2860
P1476
Histone deacetylase inhibitors in oral squamous cell carcinoma treatment
@en
P2093
Efstratios Patsouris
Evangelos Manolis
Stamatios Theocharis
P2860
P356
10.1517/13543784.2014.952368
P407
P577
2014-09-12T00:00:00Z